- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
BNIP3 Antibody / Hypoxia-Induced Apoptosis Protein Antibody is designed for the study of a mitochondrial protein that plays central roles in hypoxia-induced cell death, mitophagy, and cellular adaptation to metabolic stress. BNIP3 is a pro-apoptotic member of the BCL2 protein family that is strongly induced by hypoxia through hypoxia-inducible factor 1 signaling. Localized primarily to the outer mitochondrial membrane, BNIP3 regulates mitochondrial integrity by promoting selective mitochondrial turnover, influencing apoptosis, and coordinating cellular responses to oxygen deprivation. These activities allow BNIP3 to function as an important regulator of mitochondrial quality control and energy homeostasis.
Under physiological conditions, BNIP3 expression is relatively low in many cell types but increases rapidly during hypoxia, ischemia, nutrient deprivation, and other forms of cellular stress. Through interactions with anti-apoptotic BCL2 family proteins and components of the autophagy machinery, BNIP3 can promote mitochondrial depolarization, mitophagy, and programmed cell death depending on the cellular context. Its LC3-interacting region enables recruitment of autophagic membranes to damaged mitochondria, making BNIP3 a key mediator linking hypoxia signaling with mitochondrial quality control. Consequently, BNIP3 has become an important biomarker in studies of autophagy, mitochondrial biology, and cellular stress responses.
Altered BNIP3 expression has been associated with numerous diseases including ischemic injury, heart disease, neurodegenerative disorders, liver disease, and many human cancers. In tumors, BNIP3 may function either as a tumor suppressor or as a survival factor depending on the tissue type and microenvironment, particularly within hypoxic tumor regions. Its expression has therefore been investigated as both a prognostic biomarker and a potential therapeutic target in oncology. Continued research is expanding understanding of how BNIP3 regulates apoptosis, mitophagy, and metabolic adaptation during development and disease.
An BNIP3 Antibody is a valuable reagent for detecting endogenous BNIP3 by western blotting, immunohistochemistry, immunofluorescence, immunoprecipitation, and related laboratory applications. A Hypoxia-Induced Apoptosis Protein Antibody supports investigations of mitochondrial homeostasis, hypoxia signaling, autophagy, programmed cell death, and cancer biology.
Researchers investigating hypoxia signaling, mitochondrial dysfunction, apoptosis, and tumor progression may also be interested in exploring our Cancer Marker Antibodies page for additional validated research antibodies.
Titration of the BNIP3 Antibody / Hypoxia-Induced Apoptosis Protein Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 152-187 from the human protein (BH3 domain) was used as the immunogen for this BNIP3 antibody.
Aliquot the BNIP3 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
BNIP3 Antibody for research on hypoxia signaling, apoptosis, mitophagy and mitochondrial homeostasis in cancer and stress biology - NSJ Bioreagents.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.